Literature DB >> 8789495

The biologic and clinical significance of lymphatic metastases in breast cancer.

R S Foster1.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8789495

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


× No keyword cloud information.
  20 in total

1.  Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.

Authors:  Alison L Allan; Rosamma George; Sharon A Vantyghem; Mark W Lee; Nicole C Hodgson; C Jay Engel; Ron L Holliday; David P Girvan; Leslie A Scott; Carl O Postenka; Waleed Al-Katib; Larry W Stitt; Toshimitsu Uede; Ann F Chambers; Alan B Tuck
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 2.  Lymphangiogenesis and lymphatic vessel remodelling in cancer.

Authors:  Steven A Stacker; Steven P Williams; Tara Karnezis; Ramin Shayan; Stephen B Fox; Marc G Achen
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

3.  A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes.

Authors:  Sharon A Vantyghem; Alison L Allan; Carl O Postenka; Waleed Al-Katib; Michael Keeney; Alan B Tuck; Ann F Chambers
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  MiR-34a inhibits lymphatic metastasis potential of mouse hepatoma cells.

Authors:  Yanjie Guo; Sheng Li; Jianhua Qu; Shujing Wang; Yibing Dang; Jianhui Fan; Shengjin Yu; Jianing Zhang
Journal:  Mol Cell Biochem       Date:  2011-05-07       Impact factor: 3.396

Review 5.  [Molecular biology approach to explain lymphatic metastasis].

Authors:  F Vom Dorp; B Wullich; E Gulbins; A Eisenhardt
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

6.  The role of lymph node metastasis in the systemic dissemination of breast cancer.

Authors:  S David Nathanson; David Kwon; Alissa Kapke; Sharon Hensley Alford; Dhananjay Chitale
Journal:  Indian J Surg Oncol       Date:  2011-03-29

7.  How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?

Authors:  Min Yi; Funda Meric-Bernstam; Merrick I Ross; Jeri S Akins; Rosa F Hwang; Anthony Lucci; Henry M Kuerer; Gildy V Babiera; Michael Z Gilcrease; Kelly K Hunt
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

8.  Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy.

Authors:  Jacqueline S Jeruss; Lisa A Newman; Gregory D Ayers; Massimo Cristofanilli; Kristine R Broglio; Funda Meric-Bernstam; Min Yi; Jennifer F Waljee; Merrick I Ross; Kelly K Hunt
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

9.  Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.

Authors:  Min Yi; Savitri Krishnamurthy; Henry M Kuerer; Funda Meric-Bernstam; Isabelle Bedrosian; Merrick I Ross; Frederick C Ames; Anthony Lucci; Rosa F Hwang; Kelly K Hunt
Journal:  Am J Surg       Date:  2008-04-23       Impact factor: 2.565

10.  Hypoxia increases breast cancer cell-induced lymphatic endothelial cell migration.

Authors:  Maria Mikhaylova; Noriko Mori; Flonné B Wildes; Piotr Walczak; Barjor Gimi; Zaver M Bhujwalla
Journal:  Neoplasia       Date:  2008-04       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.